XML 17 R7.htm IDEA: XBRL DOCUMENT

Consolidated Schedule of Investments (Unaudited)

3 Months Ended

Mar. 31, 2023

Consolidated Schedule of Investments (Unaudited)

March 31, 2023

(Dollars in thousands)

Portfolio Company (1)(3)	*Sector*	*Type of Investment (7)*	*Cash Rate (4)*			*Index*	*Margin*			*Floor*			*Ceiling*			*ETP (10)*			*Maturity Date*	*Principal Amount*		*Cost of Investments (6)(9)*		*Fair Value (9)*
Non-Affiliate Investments — 222.1% (8)
Non-Affiliate Debt Investments — 212.8% (8)
Non-Affiliate Debt Investments — Life Science — 95.7% (8)
Avalo Therapeutics, Inc. (2)(5)(12)	Biotechnology	Term Loan		14.25	%	Prime		6.25	%		9.50	%		-			3.00	%	January 1, 2025	$	2,913	$	2,860	$	2,779
		Term Loan		14.25	%	Prime		6.25	%		9.50	%		-			3.00	%	January 1, 2025		2,885		2,832		2,752
		Term Loan		14.25	%	Prime		6.25	%		9.50	%		-			3.00	%	January 1, 2025		1,442		1,416		1,375
		Term Loan		14.25	%	Prime		6.25	%		9.50	%		-			3.00	%	February 1, 2025		2,885		2,829		2,749
		Term Loan		14.25	%	Prime		6.25	%		9.50	%		-			3.00	%	February 1, 2025		2,885		2,829		2,749
		Term Loan		14.25	%	Prime		6.25	%		9.50	%		-			3.00	%	April 1, 2025		1,442		1,412		1,370
		Term Loan		14.25	%	Prime		6.25	%		9.50	%		-			3.00	%	April 1, 2025		1,442		1,412		1,370
Castle Creek Biosciences, Inc. (2)(12)	Biotechnology	Term Loan		12.88	%	Prime		6.05	%		9.55	%		13.50	%		5.50	%	May 1, 2026		5,000		4,895		4,895
		Term Loan		12.88	%	Prime		6.05	%		9.55	%		13.50	%		5.50	%	May 1, 2026		5,000		4,967		4,967
		Term Loan		12.88	%	Prime		6.05	%		9.55	%		13.50	%		5.50	%	May 1, 2026		3,000		2,977		2,977
		Term Loan		12.88	%	Prime		6.05	%		9.55	%		13.50	%		5.50	%	May 1, 2026		5,000		4,967		4,967
		Term Loan		12.88	%	Prime		6.05	%		9.55	%		13.50	%		5.50	%	May 1, 2026		5,000		4,970		4,970
		Term Loan		12.88	%	Prime		6.05	%		9.55	%		13.50	%		5.50	%	May 1, 2026		3,000		2,980		2,980
Emalex Biosciences, Inc. (2)(12)	Biotechnology	Term Loan		12.57	%	Libor		4.72	%		9.75	%		-			5.00	%	June 1, 2024		1,979		1,965		1,965
		Term Loan		12.57	%	Libor		4.72	%		9.75	%		-			5.00	%	June 1, 2024		1,979		1,966		1,966
		Term Loan		12.57	%	Libor		4.72	%		9.75	%		-			5.00	%	November 1, 2025		5,000		4,930		4,930
		Term Loan		12.57	%	Libor		4.72	%		9.75	%		-			5.00	%	May 1, 2026		5,000		4,921		4,921
Evelo Biosciences, Inc. (2)(5)(12)	Biotechnology	Term Loan		12.25	%	Prime		4.25	%		11.00	%		-			4.25	%	January 1, 2028		10,000		9,880		9,880
		Term Loan		12.25	%	Prime		4.25	%		11.00	%		-			4.25	%	January 1, 2028		15,000		14,819		14,819
		Term Loan		12.25	%	Prime		4.25	%		11.00	%		-			4.25	%	January 1, 2028		6,000		5,928		5,928
		Term Loan		12.25	%	Prime		4.25	%		11.00	%		-			4.25	%	January 1, 2028		6,000		5,928		5,928
		Term Loan		12.25	%	Prime		4.25	%		11.00	%		-			4.25	%	January 1, 2028		4,000		3,952		3,952
		Term Loan		12.25	%	Prime		4.25	%		11.00	%		-			4.25	%	January 1, 2028		4,000		3,952		3,952
Greenlight Biosciences, Inc. (2)(5)(12)	Biotechnology	Term Loan		13.75	%	Prime		5.75	%		9.00	%		-			3.00	%	July 1, 2025		4,500		4,371		4,352
		Term Loan		13.75	%	Prime		5.75	%		9.00	%		-			3.00	%	July 1, 2025		2,250		2,187		2,177
IMV Inc. (2)(5)(12)	Biotechnology	Term Loan		13.75	%	Prime		5.75	%		9.00	%		-			5.00	%	July 1, 2025		5,000		4,951		4,759
		Term Loan		13.75	%	Prime		5.75	%		9.00	%		-			5.00	%	July 1, 2025		2,500		2,476		2,380
		Term Loan		13.75	%	Prime		5.75	%		9.00	%		-			5.00	%	January 1, 2026		5,000		4,953		4,761
		Term Loan		13.75	%	Prime		5.75	%		9.00	%		-			5.00	%	January 1, 2026		5,000		4,953		4,761
KSQ Therapeutics, Inc. (2) (12)	Biotechnology	Term Loan		12.75	%	Prime		4.75	%		8.50	%		-			5.50	%	May 1, 2027		6,250		6,082		6,082
		Term Loan		12.75	%	Prime		4.75	%		8.50	%		-			5.50	%	May 1, 2027		6,250		6,182		6,182
Native Microbials, Inc (2) (12)	Biotechnology	Term Loan		13.25	%	Prime		5.25	%		8.50	%		-			5.00	%	November 1, 2026		3,750		3,707		3,707
		Term Loan		13.25	%	Prime		5.25	%		8.50	%		-			5.00	%	November 1, 2026		2,500		2,472		2,472
PDS Biotechnology Corporation (2)(5)(12)	Biotechnology	Term Loan		13.75	%	Prime		5.75	%		9.75	%		-			3.75	%	September 1, 2026		10,000		9,714		9,714
		Term Loan		13.75	%	Prime		5.75	%		9.75	%		-			3.75	%	September 1, 2026		3,750		3,702		3,702
		Term Loan		13.75	%	Prime		5.75	%		9.75	%		-			3.75	%	September 1, 2026		3,750		3,702		3,702
Provivi, Inc. (2)(12)	Biotechnology	Term Loan		13.17	%	Libor		8.50	%		9.50	%		-			5.50	%	December 1, 2024		4,667		4,606		4,606
		Term Loan		13.17	%	Libor		8.50	%		9.50	%		-			5.50	%	December 1, 2024		4,667		4,606		4,606
		Term Loan		13.17	%	Libor		8.50	%		9.50	%		-			5.50	%	December 1, 2024		2,333		2,287		2,287
		Term Loan		13.17	%	Libor		8.50	%		9.50	%		-			5.50	%	December 1, 2024		2,333		2,287		2,287
		Term Loan		13.17	%	Libor		8.50	%		9.50	%		-			5.50	%	December 1, 2024		2,333		2,282		2,282
		Term Loan		13.17	%	Libor		8.50	%		9.50	%		-			5.50	%	December 1, 2024		2,333		2,282		2,282

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments (Unaudited)

March 31, 2023

(Dollars in thousands)

Portfolio Company (1)(3)	*Sector*	*Type of Investment (7)*	*Cash Rate (4)*			*Index*	*Margin*			*Floor*			*Ceiling*		*ETP (10)*			*Maturity Date*	*Principal Amount*		*Cost of Investments (6)(9)*		*Fair Value (9)*
Stealth Biotherapeutics Inc. (2)(12)	Biotechnology	Term Loan		13.50	%	Prime		5.50	%		8.75	%		-		6.00	%	October 1, 2025		5,000		4,922		4,922
		Term Loan		13.50	%	Prime		5.50	%		8.75	%		-		6.00	%	October 1, 2025		2,500		2,461		2,461
Aerobiotix, LLC (2)(12)	Medical Device	Term Loan		14.25	%	Prime		6.25	%		9.50	%		-		6.00	%	April 1, 2026		2,500		2,467		2,361
		Term Loan		14.25	%	Prime		6.25	%		9.50	%		-		6.00	%	April 1, 2026		2,500		2,467		2,361
Ceribell, Inc. (2)(12)	Medical Device	Term Loan		11.25	%	Prime		3.50	%		8.25	%		-		5.50	%	October 1, 2024		5,000		4,977		4,977
		Term Loan		11.25	%	Prime		3.50	%		8.25	%		-		5.50	%	October 1, 2024		5,000		4,977		4,977
		Term Loan		11.25	%	Prime		3.50	%		8.25	%		-		5.50	%	October 1, 2024		2,500		2,481		2,481
		Term Loan		11.25	%	Prime		3.50	%		8.25	%		-		5.50	%	October 1, 2024		2,500		2,481		2,481
Cognoa, Inc. (2)(12)	Medical Device	Term Loan		13.50	%	Prime		5.50	%		8.75	%		-		6.00	%	August 1, 2026		5,000		4,940		4,940
		Term Loan		13.50	%	Prime		5.50	%		8.75	%		-		6.00	%	August 1, 2026		2,500		2,470		2,470
Conventus Orthopaedics, Inc. (2)(12)	Medical Device	Term Loan		12.67	%	Libor		8.00	%		9.25	%		-		10.36	%	July 1, 2025		3,960		3,904		3,904
		Term Loan		12.67	%	Libor		8.00	%		9.25	%		-		10.36	%	July 1, 2025		3,960		3,904		3,904
Corinth Medtech, Inc. (2)(12)	Medical Device	Term Loan		13.00	% (11)	Prime		5.25	%		8.50	%		-		20.00	%	June 30, 2023		2,528		2,528		2,528
		Term Loan		13.00	% (11)	Prime		5.25	%		8.50	%		-		20.00	%	June 30, 2023		2,528		2,528		2,528
		Term Loan		13.00	% (11)	Prime		5.25	%		8.50	%		-		50.00	%	June 30, 2023		200		200		200
CSA Medical, Inc. (2)(12)	Medical Device	Term Loan		12.87	%	Libor		8.20	%		10.00	%		-		5.00	%	January 1, 2024		1,250		1,239		1,239
		Term Loan		12.87	%	Libor		8.20	%		10.00	%		-		5.00	%	January 1, 2024		83		83		83
		Term Loan		12.87	%	Libor		8.20	%		10.00	%		-		5.00	%	March 1, 2024		1,600		1,587		1,587
InfoBionic, Inc. (2)(12)	Medical Device	Term Loan		14.00	%	Prime		6.25	%		9.50	%		-		4.00	%	October 1, 2024		2,771		2,715		2,715
		Term Loan		14.00	%	Prime		6.25	%		9.50	%		-		4.00	%	June 1, 2025		1,000		977		977
Magnolia Medical Technologies, Inc. (2)(12)	Medical Device	Term Loan		12.75	%	Prime		5.00	%		9.75	%		-		4.00	%	March 1, 2025		5,000		4,946		4,946
		Term Loan		12.75	%	Prime		5.00	%		9.75	%		-		4.00	%	March 1, 2025		5,000		4,946		4,946
		Term Loan		12.75	%	Prime		5.00	%		9.75	%		-		4.00	%	March 1, 2025		5,000		4,940		4,940
		Term Loan		12.75	%	Prime		5.00	%		9.75	%		-		4.00	%	March 1, 2025		5,000		4,941		4,941
		Term Loan		12.75	%	Prime		5.00	%		9.75	%		-		4.00	%	January 1, 2027		5,000		4,920		4,920
		Term Loan		12.75	%	Prime		5.00	%		9.75	%		-		4.00	%	January 1, 2027		5,000		4,920		4,920
Robin Healthcare, Inc. (2)(12)	Medical Device	Term Loan		13.50	%	Prime		5.50	%		10.25	%		-		4.00	%	November 1, 2026		3,500		3,413		3,413
		Term Loan		13.50	%	Prime		5.50	%		10.25	%		-		4.00	%	November 1, 2026		3,500		3,463		3,463
Scientia Vascular, Inc. (2)(12)	Medical Device	Term Loan		12.50	%	Prime		4.75	%		8.50	%		-		5.00	%	January 1, 2027		3,750		3,601		3,601
		Term Loan		12.50	%	Prime		4.75	%		8.50	%		-		5.00	%	January 1, 2027		3,750		3,710		3,710
Sonex Health, Inc. (2)(12)	Medical Device	Term Loan		14.25	%	Prime		6.50	%		9.75	%		-		8.00	%	June 1, 2025		2,500		2,478		2,478
		Term Loan		14.25	%	Prime		6.50	%		9.75	%		-		8.00	%	June 1, 2025		2,500		2,478		2,478
		Term Loan		14.25	%	Prime		6.50	%		9.75	%		-		8.00	%	June 1, 2025		2,500		2,478		2,478
		Term Loan		14.25	%	Prime		6.50	%		9.75	%		-		8.00	%	April 1, 2026		2,500		2,459		2,459
		Term Loan		14.25	%	Prime		6.50	%		9.75	%		-		8.00	%	May 1, 2026		2,500		2,458		2,458
Spineology, Inc. (2)(12)	Medical Device	Term Loan		15.00	%	Prime		7.00	%		10.25	%		-		1.00	%	October 1, 2025		5,000		4,969		4,969
		Term Loan		15.00	%	Prime		7.00	%		10.25	%		-		1.00	%	April 1, 2026		2,500		2,483		2,483

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments (Unaudited)

March 31, 2023

(Dollars in thousands)

Portfolio Company (1)(3)	*Sector*	*Type of Investment (7)*	*Cash Rate (4)*			*Index*	*Margin*			*Floor*			*Ceiling*		*ETP (10)*			*Maturity Date*	*Principal Amount*		*Cost of Investments (6)(9)*		*Fair Value (9)*
Swift Health Systems Inc. (2)(12)	Medical Device	Term Loan		13.00	%	Prime		5.25	%		9.00	%		-		5.00	%	July 1, 2027		3,500		3,457		3,457
		Term Loan		13.00	%	Prime		5.25	%		9.00	%		-		5.00	%	July 1, 2027		3,500		3,457		3,457
		Term Loan		13.25	%	Prime		5.25	%		9.00	%		-		5.00	%	July 1, 2027		3,500		3,447		3,447
		Term Loan		13.25	%	Prime		5.25	%		9.00	%		-		5.00	%	July 1, 2027		3,500		3,447		3,447
Total Non-Affiliate Debt Investments — Life Science																						309,108		307,749
Non-Affiliate Debt Investments — Sustainability — 25.8% (8)
Aerofarms, Inc. (2)(12)	Other Sustainability	Term Loan		14.75	%	Prime		6.75	%		10.00	%		-		3.00	%	April 1, 2026		3,750		3,704		3,585
		Term Loan		14.75	%	Prime		6.75	%		10.00	%		-		3.00	%	April 1, 2026		3,750		3,704		3,585
Nexii Building Solutions, Inc. (2)(12)	Other Sustainability	Term Loan		15.00	%	Prime		7.00	%		10.25	%		-		2.50	%	September 1, 2025		7,500		7,383		7,245
		Term Loan		15.00	%	Prime		7.00	%		10.25	%		-		2.50	%	September 1, 2025		7,500		7,383		7,245
		Term Loan		15.00	%	Prime		7.00	%		10.25	%		-		2.50	%	September 1, 2025		7,500		7,383		7,245
		Term Loan		15.00	%	Prime		7.00	%		10.25	%		-		2.50	%	July 1, 2026		5,000		4,912		4,820
		Term Loan		15.00	%	Prime		7.00	%		10.25	%		-		2.50	%	July 1, 2026		5,000		4,912		4,820
Soli Organic, Inc. (2)(12)	Other Sustainability	Term Loan		14.75	%	Prime		6.75	%		10.00	%		-		2.75	%	April 1, 2026		5,000		4,935		4,935
		Term Loan		14.75	%	Prime		6.75	%		10.00	%		-		2.75	%	April 1, 2026		2,500		2,467		2,467
		Term Loan		14.75	%	Prime		6.75	%		10.00	%		-		2.75	%	May 1, 2026		5,000		4,932		4,932
		Term Loan		14.75	%	Prime		6.75	%		10.00	%		-		2.75	%	May 1, 2026		2,500		2,466		2,466
		Term Loan		13.50	%	Prime		5.50	%		11.75	%		-		2.75	%	December 1, 2026		5,000		4,909		4,909
		Term Loan		13.50	%	Prime		5.50	%		11.75	%		-		2.75	%	December 1, 2026		2,500		2,454		2,454
Temperpack Technologies, Inc. (2)(12)	Other Sustainability	Term Loan		14.75	%	Prime		6.75	%		10.00	%		-		2.50	%	June 1, 2025		3,750		3,706		3,706
		Term Loan		14.75	%	Prime		6.75	%		10.00	%		-		2.50	%	June 1, 2025		3,750		3,720		3,720
		Term Loan		14.75	%	Prime		6.75	%		10.00	%		-		2.50	%	October 1, 2025		7,500		7,431		7,431
		Term Loan		14.75	%	Prime		6.75	%		10.00	%		-		2.50	%	October 1, 2025		3,750		3,715		3,715
		Term Loan		14.75	%	Prime		6.75	%		10.00	%		-		2.50	%	October 1, 2025		3,750		3,715		3,715
Total Non-Affiliate Debt Investments — Sustainability																						83,831		82,995
Non-Affiliate Debt Investments — Technology — 83.2% (8)
Axiom Space, Inc. (2)(12)	Communications	Term Loan		13.75	%	Prime		6.00	%		9.25	%		-		2.50	%	June 1, 2026		7,500		7,459		7,459
		Term Loan		13.75	%	Prime		6.00	%		9.25	%		-		2.50	%	June 1, 2026		7,500		7,459		7,459
		Term Loan		13.75	%	Prime		6.00	%		9.25	%		-		2.50	%	June 1, 2026		7,500		7,459		7,459
Better Place Forests Co. (12)(13)	Consumer-related Technologies	Term Loan		14.25	%	Prime		6.25	%		9.50	%		-		1.85	%	July 1, 2025		5,000		4,951		3,467
		Term Loan		14.25	%	Prime		6.25	%		9.50	%		-		1.85	%	October 1, 2025		2,500		2,474		1,733
CAMP NYC, Inc. (2)(12)	Consumer-related Technologies	Term Loan		15.25	%	Prime		7.25	%		10.50	%		-		3.00	%	May 1, 2026		3,500		3,464		3,464
Clara Foods Co. (2)(12)	Consumer-related Technologies	Term Loan		13.50	%	Prime		5.75	%		9.00	%		-		5.50	%	August 1, 2025		2,333		2,318		2,318
		Term Loan		13.50	%	Prime		5.75	%		9.00	%		-		5.50	%	August 1, 2025		2,333		2,318		2,318

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments (Unaudited)

March 31, 2023

(Dollars in thousands)

Portfolio Company (1)(3)	*Sector*	*Type of Investment (7)*	*Cash Rate (4)*			*Index*	*Margin*			*Floor*			*Ceiling*			*ETP (10)*			*Maturity Date*	*Principal Amount*		*Cost of Investments (6)(9)*		*Fair Value (9)*
Divergent Technologies, Inc. (2)(12)	Consumer-related Technologies	Term Loan		11.25	%	Prime		6.00	%		9.50	%		11.25	%		3.00	%	July 1, 2027		3,750		3,520		3,520
		Term Loan		11.25	%	Prime		6.00	%		9.50	%		11.25	%		3.00	%	July 1, 2027		1,250		1,239		1,239
		Term Loan		11.25	%	Prime		6.00	%		9.50	%		11.25	%		3.00	%	July 1, 2027		3,750		3,717		3,717
		Term Loan		11.25	%	Prime		6.00	%		9.50	%		11.25	%		3.00	%	July 1, 2027		1,250		1,239		1,239
		Term Loan		11.25	%	Prime		6.00	%		9.50	%		11.25	%		3.00	%	July 1, 2027		3,750		3,717		3,717
		Term Loan		11.25	%	Prime		6.00	%		9.50	%		11.25	%		3.00	%	July 1, 2027		1,250		1,239		1,239
		Term Loan		11.25	%	Prime		6.00	%		9.50	%		11.25	%		3.00	%	January 1, 2028		3,750		3,701		3,701
		Term Loan		11.25	%	Prime		6.00	%		9.50	%		11.25	%		3.00	%	January 1, 2028		3,750		3,701		3,701
		Term Loan		11.25	%	Prime		6.00	%		9.50	%		11.25	%		3.00	%	April 1, 2028		3,750		3,698		3,698
Havenly, Inc. (2)(12)	Consumer-related Technologies	Term Loan		13.00	%	Prime		5.00	%		5.00	%		-			4.00	%	March 1, 2027		2,000		1,165		1,165
		Term Loan		13.00	%	Prime		5.00	%		5.00	%		-			4.00	%	March 1, 2027		3,000		1,748		1,748
		Term Loan		11.50	%	Prime		3.50	%		10.50	%		-			7.78	%	February 1, 2028		2,813		2,813		2,813
		Term Loan		11.50	%	Prime		3.50	%		10.50	%		-			7.78	%	February 1, 2028		2,813		2,813		2,813
Interior Define, Inc. (2)(12)(13)	Consumer-related Technologies	Term Loan		14.50	%	Prime		6.50	%		9.75	%		-			4.00	%	January 1, 2026		3,246		3,162		—
		Term Loan		14.50	%	Prime		6.50	%		9.75	%		-			4.00	%	January 1, 2026		2,963		2,886		—
Lyrical Foods, Inc. (2)(12)	Consumer-related Technologies	Term Loan		10.50	%	Prime		2.50	%		8.00	%		-			-		September 1, 2027		2,598		2,586		2,330
MyForest Foods Co. (2)(12)	Consumer-related Technologies	Term Loan		14.75	%	Prime		6.75	%		10.00	%		-			3.00	%	October 1, 2025		5,000		4,961		4,961
		Term Loan		14.75	%	Prime		6.75	%		10.00	%		-			3.00	%	October 1, 2025		2,500		2,480		2,480
NextCar Holding Company, Inc. (2)(12)	Consumer-related Technologies	Term Loan		13.50	% (11)	Prime		5.75	%		9.00	%		-			5.25	%	October 31, 2023		5,169		5,121		4,883
		Term Loan		13.50	% (11)	Prime		5.75	%		9.00	%		-			5.25	%	October 31, 2023		2,067		2,050		1,955
		Term Loan		13.50	% (11)	Prime		5.75	%		9.00	%		-			5.25	%	October 31, 2023		2,584		2,564		2,446
		Term Loan		13.50	% (11)	Prime		5.75	%		9.00	%		-			5.25	%	October 31, 2023		3,101		3,076		2,934
		Term Loan		13.50	% (11)	Prime		5.75	%		9.00	%		-			5.25	%	October 31, 2023		2,584		2,548		2,430
		Term Loan		13.50	% (11)	Prime		5.75	%		9.00	%		-			5.25	%	October 31, 2023		2,584		2,548		2,430
		Term Loan		13.50	% (11)	Prime		5.75	%		9.00	%		-			5.25	%	October 31, 2023		5,169		5,093		4,859
		Term Loan		13.50	% (11)	Prime		5.75	%		9.00	%		-			5.25	%	October 31, 2023		2,584		2,545		2,428
Optoro, Inc. (2)(12)	Consumer-related Technologies	Term Loan		14.00	%	Prime		6.25	%		9.50	%		-			4.00	%	August 1, 2027		2,500		2,355		2,355
Primary Kids, Inc. (2)(12)	Consumer-related Technologies	Term Loan		15.00	%	Prime		7.25	%		10.50	%		-			3.00	%	March 1, 2025		2,300		2,277		2,277
		Term Loan		15.00	%	Prime		7.25	%		10.50	%		-			3.00	%	March 1, 2025		2,300		2,277		2,277
		Term Loan		15.00	%	Prime		7.25	%		10.50	%		-			3.00	%	September 1, 2025		2,900		2,870		2,870
Unagi, Inc. (2)(12)	Consumer-related Technologies	Term Loan		15.75	% (11)	Prime		7.75	%		11.00	%		-			-		May 1, 2027		1,065		1,041		1,041
		Term Loan		15.75	% (11)	Prime		7.75	%		11.00	%		-			-		May 1, 2027		533		520		520
		Term Loan		15.75	% (11)	Prime		7.75	%		11.00	%		-			-		May 1, 2027		533		521		521
Liqid, Inc. (2)(12)	Networking	Term Loan		14.00	%	Prime		6.25	%		9.50	%		-			4.00	%	September 1, 2024		2,833		2,793		2,793
		Term Loan		14.00	%	Prime		6.25	%		9.50	%		-			4.00	%	September 1, 2024		2,833		2,793		2,793
		Term Loan		14.00	%	Prime		6.25	%		9.50	%		-			4.00	%	September 1, 2024		1,417		1,395		1,395
		Term Loan		14.00	%	Prime		6.25	%		9.50	%		-			4.00	%	September 1, 2024		1,417		1,395		1,395
		Term Loan		14.00	%	Prime		6.25	%		9.50	%		-			4.00	%	September 1, 2024		1,417		1,371		1,371
BriteCore Holdings, Inc. (2)(12)	Software	Term Loan		14.50	%	Prime		6.75	%		10.00	%		-			5.00	%	March 1, 2026		2,500		2,488		2,488
		Term Loan		14.50	%	Prime		6.75	%		10.00	%		-			5.00	%	March 1, 2026		2,500		2,488		2,488
		Term Loan		14.50	%	Prime		6.75	%		10.00	%		-			3.00	%	March 1, 2027		2,500		2,467		2,467
		Term Loan		14.50	%	Prime		6.75	%		10.00	%		-			3.00	%	March 1, 2027		2,500		2,467		2,467
Decisyon, Inc. (12)	Software	Term Loan		17.43	%	Prime		9.43	%		12.68	%		-			50.43	%	December 31, 2022		3,284		3,284		2,750

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments (Unaudited)

March 31, 2023

(Dollars in thousands)

Portfolio Company (1)(3)	*Sector*	*Type of Investment (7)*	*Cash Rate (4)*			*Index*	*Margin*			*Floor*			*Ceiling*			*ETP (10)*			*Maturity Date*	*Principal Amount*		*Cost of Investments (6)(9)*		*Fair Value (9)*
Dropoff, Inc. (2)(12)	Software	Term Loan		14.50	%	Prime		6.50	%		9.75	%		-			3.50	%	April 1, 2026		6,500		6,359		6,359
		Term Loan		14.50	%	Prime		6.50	%		9.75	%		-			3.50	%	April 1, 2026		6,000		5,869		5,869
		Term Loan		14.50	%	Prime		6.50	%		9.75	%		-			3.50	%	August 1, 2026		2,500		2,442		2,442
Engage3, LLC (2)(12)	Software	Term Loan		14.00	%	Prime		6.25	%		9.75	%		-			4.50	%	July 1, 2027		3,750		3,680		3,680
		Term Loan		14.00	%	Prime		6.25	%		9.75	%		-			4.50	%	July 1, 2027		3,750		3,720		3,720
Groundspeed Analytics, Inc. (2)(12)	Software	Term Loan		13.50	%	Prime		5.50	%		11.00	%		18.00	%		3.00	%	December 1, 2026		5,000		4,802		4,802
		Term Loan		13.50	%	Prime		5.50	%		11.00	%		18.00	%		3.00	%	December 1, 2026		5,000		4,953		4,953
		Convertible Note		15.00	%														September 10,2024		500		500		500
Kodiak Robotics, Inc. (2)(12)	Software	Term Loan		13.50	%	Prime		5.50	%		10.25	%		-			4.00	%	April 1, 2026		10,000		9,843		9,843
		Term Loan		13.50	%	Prime		5.50	%		10.25	%		-			4.00	%	April 1, 2026		10,000		9,843		9,843
		Term Loan		13.50	%	Prime		5.50	%		10.25	%		-			4.00	%	April 1, 2026		5,000		4,921		4,921
		Term Loan		13.50	%	Prime		5.50	%		10.25	%		-			4.00	%	April 1, 2026		5,000		4,921		4,921
Lemongrass Holdings, Inc. (2)(12)	Software	Term Loan		14.50	%	Prime		6.50	%		9.75	%		-			2.50	%	March 1, 2026		5,000		4,953		4,953
		Term Loan		14.50	%	Prime		6.50	%		9.75	%		-			2.50	%	March 1, 2026		2,500		2,477		2,477
Lytics, Inc. (2)(12)	Software	Term Loan		13.75	%	Prime		6.00	%		9.25	%		-			3.00	%	November 1, 2026		2,500		2,411		2,411
		Term Loan		13.75	%	Prime		6.00	%		12.25	%		-			3.00	%	December 1, 2026		1,250		1,232		1,232
		Term Loan		13.75	%	Prime		6.00	%		12.25	%		-			3.00	%	April 1, 2027		1,000		984		984
Noodle Partners, Inc. (2)(12)	Software	Term Loan		13.00	%	Prime		5.00	%		12.00	%		-			3.00	%	March 1, 2027		10,000		9,733		9,733
		Term Loan		13.00	%	Prime		5.00	%		12.00	%		-			3.00	%	March 1, 2027		5,000		4,928		4,928
		Term Loan		13.00	%	Prime		5.00	%		12.00	%		-			3.00	%	March 1, 2027		5,000		4,928		4,928
Reputation Institute, Inc. (2)(12)	Software	Term Loan		15.00	%	Prime		7.25	%		10.50	%		-			3.00	%	August 1, 2025		4,833		4,772		4,772
Slingshot Aerospace, Inc. (2)(12)	Software	Term Loan		13.75	%	Prime		5.75	%		9.75	%		-			5.00	%	August 1, 2026		5,000		4,940		4,940
		Term Loan		13.75	%	Prime		5.75	%		9.75	%		-			5.00	%	August 1, 2026		5,000		4,940		4,940
		Term Loan		13.75	%	Prime		5.75	%		9.75	%		-			5.00	%	August 1, 2026		5,000		4,875		4,875
		Term Loan		13.75	%	Prime		5.75	%		9.75	%		-			5.00	%	August 1, 2026		5,000		4,940		4,940
Supply Network Visibility Holdings LLC (2)(12)	Software	Term Loan		14.25	%	Prime		6.50	%		9.75	%		-			4.00	%	February 1, 2025		3,208		3,183		3,183
		Term Loan		14.25	%	Prime		6.50	%		9.75	%		-			4.00	%	February 1, 2025		3,208		3,183		3,183
		Term Loan		14.25	%	Prime		6.50	%		9.75	%		-			4.00	%	December 1, 2025		2,500		2,475		2,475
		Term Loan		14.25	%	Prime		6.50	%		9.75	%		-			4.00	%	December 1, 2025		2,500		2,475		2,475
Total Non-Affiliate Debt Investments — Technology																							277,916		267,673
Non-Affiliate Debt Investments — Healthcare information and services — 8.1% (8)
Hound Labs inc. (2) (12)	Diagnostics	Term Loan		14.00	%	Prime		6.00	%		9.25	%		-			3.50	%	June 1, 2026		2,500		2,388		2,388
		Term Loan		14.00	%	Prime		6.00	%		9.25	%		-			3.50	%	June 1, 2026		2,500		2,476		2,476
		Term Loan		14.00	%	Prime		6.00	%		9.25	%		-			3.50	%	June 1, 2026		5,000		4,951		4,951
Secure Transfusion Services, Inc. (12)(13)	Other Healthcare	Term Loan		13.75	%	Prime		5.75	%		9.00	%		-			4.00	%	October 1, 2025		4,719		4,658		46
		Term Loan		13.75	%	Prime		5.75	%		9.00	%		-			4.00	%	December 31, 2025		2,217		2,182		5
BrightInsight, Inc. (2)(12)	Software	Term Loan		13.25	%	Prime		5.50	%		9.50	%		-			3.00	%	August 1, 2027		7,000		6,663		6,663
		Term Loan		13.25	%	Prime		5.50	%		9.50	%		-			3.00	%	August 1, 2027		3,500		3,452		3,452
		Term Loan		13.25	%	Prime		5.50	%		9.50	%		-			3.00	%	August 1, 2027		3,500		3,452		3,452
		Term Loan		13.50	%	Prime		5.50	%		9.50	%		-			3.00	%	April 1, 2028		2,750		2,704		2,704
Total Non-Affiliate Debt Investments — Healthcare information and services																							32,926		26,137
*Total Non- Affiliate Debt Investments*																							703,781		684,554

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments (Unaudited)

March 31, 2023

(Dollars in thousands)

					*Cost of*		*Fair*
Portfolio Company (1)(3)	*Sector*	*Type of Investment (7)*	*Number of Shares*		*Investments (6)(9)*		*Value (9)*
Non-Affiliate Warrant Investments — 8.0% (8)
Non-Affiliate Warrants — Life Science — 2.1% (8)
Avalo Therapeutics, Inc. (2)(5)(12)	Biotechnology	Common Stock Warrant		26,444		311		—
Castle Creek Biosciences, Inc. (2)(12)	Biotechnology	Preferred Stock Warrant		7,404		214		329
Corvium, Inc. (2)(12)	Biotechnology	Preferred Stock Warrant		661,956		53		—
Emalex Biosciences, Inc. (2)(12)	Biotechnology	Preferred Stock Warrant		110,402		176		256
Evelo Biosciences, Inc. (2)(5)(12)	Biotechnology	Common Stock Warrant		463,915		126		—
Greenlight Biosciences, Inc. (2)(5)(12)	Biotechnology	Common Stock Warrant		47,452		366		—
Imunon, Inc. (2)(5)(12)	Biotechnology	Common Stock Warrant		19,671		66		—
IMV Inc. (2)(5)(12)	Biotechnology	Common Stock Warrant		39,774		67		—
KSQ Therapeutics, Inc. (2) (12)	Biotechnology	Preferred Stock Warrant		48,076		50		56
Mustang Bio, Inc. (2)(5)(12)	Biotechnology	Common Stock Warrant		252,161		141		—
Native Microbials, Inc (2)(12)	Biotechnology	Preferred Stock Warrant		103,679		64		159
PDS Biotechnology Corporation (2)(5)(12)	Biotechnology	Common Stock Warrant		299,848		160		937
Provivi, Inc. (2)(12)	Biotechnology	Preferred Stock Warrant		254,609		401		128
Rocket Pharmaceuticals Corporation (5)(12)	Biotechnology	Common Stock Warrant		7,051		17		2
Stealth Biotherapeutics Inc. (2)(12)	Biotechnology	Common Stock Warrant		318,181		264		28
vTv Therapeutics Inc. (2)(5)(12)	Biotechnology	Common Stock Warrant		95,293		44		—
Xeris Pharmaceuticals, Inc. (2)(5)(12)	Biotechnology	Common Stock Warrant		126,000		72		9
AccuVein Inc. (2)(12)	Medical Device	Common Stock Warrant		1,175		24		—
Aerin Medical, Inc. (2)(12)	Medical Device	Preferred Stock Warrant		1,818,183		66		1,196
Aerobiotix, LLC (2)(12)	Medical Device	Preferred Stock Warrant		27,330		48		31
Canary Medical Inc. (2)(12)	Medical Device	Preferred Stock Warrant		12,153		86		1,862
Ceribell, Inc. (2)(12)	Medical Device	Preferred Stock Warrant		145,483		69		206
Cognoa, Inc. (2)(12)	Medical Device	Preferred Stock Warrant		775,000		144		173
Conventus Orthopaedics, Inc. (2)(12)	Medical Device	Preferred Stock Warrant		7,972,222		221		221
CSA Medical, Inc. (2)(12)	Medical Device	Preferred Stock Warrant		1,375,727		153		148
CVRx, Inc. (2)(5)(12)	Medical Device	Common Stock Warrant		47,410		76		72
Infobionic, Inc. (2)(12)	Medical Device	Preferred Stock Warrant		317,647		124		51

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments (Unaudited)

March 31, 2023

(Dollars in thousands)

					*Cost of*		*Fair*
Portfolio Company (1)(3)	*Sector*	*Type of Investment (7)*	*Number of Shares*		*Investments (6)(9)*		*Value (9)*
Magnolia Medical Technologies, Inc. (2)(12)	Medical Device	Preferred Stock Warrant		809,931		194		379
Meditrina, Inc. (2)(12)	Medical Device	Preferred Stock Warrant		233,993		83		98
Robin Healthcare, Inc. (2)(12)	Medical Device	Preferred Stock Warrant		86,066		16		15
Scientia Vascular, Inc (2)(12)	Medical Device	Preferred Stock Warrant		19,662		40		45
Sonex Health, Inc. (2)(12)	Medical Device	Preferred Stock Warrant		605,313		98		120
VERO Biotech LLC (2)(12)	Medical Device	Preferred Stock Warrant		408		53		1
Swift Health Systems Inc. (2)(12)	Medical Device	Preferred Stock Warrant		135,484		71		81
Total Non-Affiliate Warrants — Life Science						4,158		6,603
Non-Affiliate Warrants — Sustainability — 0.2% (8)
Aerofarms, Inc. (2)(12)	Other Sustainability	Preferred Stock Warrant		201,537		61		72
LiquiGlide, Inc. (2)(12)	Other Sustainability	Common Stock Warrant		61,359		39		53
Nexii Building Solutions, Inc. (2)(12)	Other Sustainability	Common Stock Warrant		204,195		490		1
Soli Organic, Inc. (2)(12)	Other Sustainability	Preferred Stock Warrant		681		214		354
Temperpack Technologies, Inc. (2)(12)	Other Sustainability	Preferred Stock Warrant		34,604		118		259
Total Non-Affiliate Warrants — Sustainability						922		739
Non-Affiliate Warrants — Technology — 5.1% (8)
Axiom Space, Inc. (2)(12)	Communications	Common Stock Warrant		1,991		46		64
Intelepeer Holdings, Inc. (2)(12)	Communications	Preferred Stock Warrant		2,936,535		138		3,251
PebblePost, Inc. (2)(12)	Communications	Preferred Stock Warrant		598,850		91		170
Alula Holdings, Inc. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		20,000		93		64
Aterian, Inc. (2)(5)(12)	Consumer-related Technologies	Common Stock Warrant		76,923		195		—
Better Place Forests Co. (12)	Consumer-related Technologies	Preferred Stock Warrant		2,672		26		—
Caastle, Inc. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		268,591		68		1,057
CAMP NYC, Inc. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		17,605		22		—
Clara Foods Co. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		46,745		30		124
Divergent Technologies, Inc. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		33,742		70		237
Havenly, Inc. (2)(12)	Consumer-related Technologies	Common Stock Warrant		1,312,500		2,942		2,674
MyForest Foods Co. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		143		29		36
NextCar Holding Company, Inc. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		1,261,253		197		17
Optoro, Inc. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		6,600		104		104
Primary Kids, Inc. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		553,778		57		427
Quip NYC Inc. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		6,191		325		532
Unagi, Inc. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		171,081		32		111
Updater, Inc.(2)(12)	Consumer-related Technologies	Common Stock Warrant		108,333		34		42
CPG Beyond, Inc. (2)(12)	Data Storage	Preferred Stock Warrant		500,000		242		903
Silk, Inc. (2)(12)	Data Storage	Preferred and Common Stock Warrant		442,110		234		399
Global Worldwide LLC (2)(12)	Internet and Media	Preferred Stock Warrant		245,810		75		—
Rocket Lawyer Incorporated (2)(12)	Internet and Media	Preferred Stock Warrant		261,721		92		352
Skillshare, Inc. (2)(12)	Internet and Media	Preferred Stock Warrant		139,074		162		1,231
Liqid, Inc. (2)(12)	Networking	Preferred Stock Warrant		344,102		364		237
Halio, Inc. (2)(12)	Power Management	Preferred Stock Warrant		5,002,574		1,585		2,808
Avalanche Technology, Inc. (2)(12)	Semiconductors	Preferred and Common Stock Warrants		6,081		57		—
BriteCore Holdings, Inc. (2)(12)	Software	Preferred Stock Warrant		77,828		21		67
Decisyon, Inc. (12)	Software	Common Stock Warrant		82,967		46		—
Dropoff, Inc. (2)(12)	Software	Common Stock Warrant		516,732		455		196
E La Carte, Inc. (2)(5)(12)	Software	Common Stock Warrant		147,361		60		—
Groundspeed Analytics, Inc. (2)(12)	Software	Preferred Stock Warrant		86,300		7		1
Kodiak Robotics, Inc. (2)(12)	Software	Preferred Stock Warrant		639,918		275		287
Lemongrass Holdings, Inc. (2)(12)	Software	Preferred Stock Warrant		101,308		35		40
Lotame Solutions, Inc. (2)(12)	Software	Preferred Stock Warrant		71,305		19		53
Lytics, Inc. (2)(12)	Software	Preferred Stock Warrant		85,543		43		46
Noodle Partners, Inc. (2)(12)	Software	Preferred Stock Warrant		84,037		116		116
Reputation Institute, Inc. (2)(12)	Software	Preferred Stock Warrant		3,731		61		46
Revinate Holdings, Inc. (2)(12)	Software	Preferred Stock Warrant		682,034		44		97
Riv Data Corp. (2)(12)	Software	Preferred Stock Warrant		321,428		12		296
SIGNiX, Inc. (12)	Software	Preferred Stock Warrant		186,235		225		—
Slingshot Aerospace, Inc. (2)(12)	Software	Preferred Stock Warrant		309,208		123		135
Supply Network Visibility Holdings LLC (2)(12)	Software	Preferred Stock Warrant		682		64		140
Topia Mobility, Inc. (2)(12)	Software	Preferred Stock Warrant		3,049,607		138		—
xAd, Inc. (2)(12)	Software	Preferred Stock Warrant		4,343,348		177		11
Total Non-Affiliate Warrants — Technology						9,231		16,371

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments (Unaudited)

March 31, 2023

(Dollars in thousands)

					*Cost of*		*Fair*
Portfolio Company (1)(3)	*Sector*	*Type of Investment (7)*	*Number of Shares*		*Investments (6)(9)*		*Value (9)*
Non-Affiliate Warrants — Healthcare information and services — 0.6% (8)
Hound Labs, Inc (2) (12)	Diagnostics	Preferred Stock Warrant		159,893		47		53
Kate Farms, Inc. (2)(12)	Other Healthcare	Preferred Stock Warrant		82,965		102		1,363
Secure Transfusion Services, Inc. (12)	Other Healthcare	Preferred Stock Warrant		77,690		48		—
BrightInsight, Inc. (2)(12)	Software	Preferred Stock Warrant		85,066		167		175
Medsphere Systems Corporation (2)(12)	Software	Preferred Stock Warrant		7,097,792		60		354
Total Non-Affiliate Warrants — Healthcare information and services						424		1,945
*Total Non-Affiliate Warrants*						14,735		25,658
Non-Affiliate Other Investments — 0.4% (8)
Lumithera, Inc. (12)	Medical Device	Royalty Agreement				1,200		1,100
ZetrOZ, Inc. (12)	Medical Device	Royalty Agreement				—		200
*Total Non-Affiliate Other Investments*						1,200		1,300
Non-Affiliate Equity — 0.9% (8)
Castle Creek Biosciences, Inc. (12)	Biotechnology	Common Stock		1,162		250		250
Emalex Biosciences, Inc. (12)	Biotechnology	Common Stock		32,831		356		356
Getaround, Inc. (2)(5)	Consumer-related Technologies	Common Stock		87,082		253		25
SnagAJob.com, Inc. (12)	Consumer-related Technologies	Common Stock		82,974		9		83
Lumithera, Inc. (12)	Medical Device	Common Stock		392,651		2,000		1,700
Tigo Energy, Inc. (12)	Other Sustainability	Preferred Stock		22,313		8		27
Branded Online, Inc. (2)(5)	Software	Common Stock		5,398		1,075		14
Decisyon, Inc. (12)	Software	Preferred and Common Stock		72,638,663		229		—
Lotame, Inc. (12)	Software	Preferred Stock		66,127		5		193
Axiom Space, Inc. (12)	Technology	Preferred Stock		1,810		261		306
*Total Non-Affiliate Equity*						4,446		2,954
*Total Non-Affiliate Portfolio Investment Assets*					$	724,162	$	714,466
Non-controlled Affiliate Investments — 0.3% (8)
Non-controlled Affiliate Equity — Life Science —0.3% (8)
Cadrenal Therapeutics, Inc. (5)	Biotechnology	Common Stock		600,000		—		846
*Total Non-Controlled Affiliate Equity*					$	—		846
*Total Non-Controlled Affiliate Portfolio Investment Assets*					$	—		846
*Total Portfolio Investment Assets — 222.4% (8)*					$	724,162	$	715,312

(1)	All investments of the Company are in entities which are organized under the laws of the United States and have a principal place of business in the United States.

(2)

Has been pledged as collateral under the revolving credit facility (the “Key Facility”) with KeyBank National Association (“Key”), the Note Funding Agreement (the “NYL Facility”, together with the Key Facility, the "Credit Facilities") with several entities owned or affiliated with New York Life Insurance Company (“NYL Noteholders”), the term debt securitization in connection with which an affiliate of the Company made an offering of $100.0 million in aggregate principal amount of fixed rate asset-backed notes that were issued in conjunction with the $160.0 million securitization of secured loans the Company completed on August 13, 2019 (the “2019 Asset-Backed Notes”), and/or the term debt securitization in connection with which an affiliate of the Company made an offering of $100.0 million in aggregate principal amount of fixed rate asset-backed notes that were issued in conjunction with the $157.8 million securitization of secured loans the Company completed on November 9, 2022 (the “2022 Asset-Backed Notes”).

(3)

All non-affiliate investments are investments in which the Company owns less than 5% of the voting securities of the portfolio company. All non-controlled affiliate investments are investments in which the Company owns 5% or more of the voting securities of the portfolio company but not more than 25% of the voting securities of the portfolio company. All controlled affiliate investments are investments in which the Company owns more than 25% of the portfolio company’s outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement).

(4)

All interest is payable in cash due monthly in arrears, unless otherwise indicated, and applies only to the Company’s debt investments. Interest rate is the annual interest rate on the debt investment and does not include end-of-term payments (“ETPs”), and any additional fees related to the investments, such as deferred interest, commitment fees or prepayment fees. Debt investments are at variable rates for the term of the debt investment, unless otherwise indicated. All debt investments based on the London InterBank Offered Rate (“LIBOR”) are based on one-month LIBOR. For each debt investment, the current interest rate in effect as of March 31, 2023 is provided.

(5)	Portfolio company is a public company.

(6)	For debt investments, represents principal balance less unearned income.

(7)	Warrants, Equity and Other Investments are non-income producing.

(8)	Value as a percent of net assets.

(9)

As of March 31, 2023, 6.3% and 6.2% of the Company’s total assets on a cost and fair value basis, respectively, are in non-qualifying assets. Under the 1940 Act, the Company may not acquire any non-qualifying assets unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company’s total assets.

(10)

ETPs are contractual fixed-interest payments due in cash at the maturity date of the applicable debt investment, including upon any prepayment, and are a fixed percentage of the original principal balance of the debt investments unless otherwise noted. Interest will accrue during the life of the debt investment on each ETP and will be recognized as non-cash income until it is actually paid. Therefore, a portion of the incentive fee the Company may pay its Advisor will be based on income that the Company has not yet received in cash.

(11)	Debt investment has a payment-in-kind (“PIK”) feature.

(12)	The fair value of the investment was valued using significant unobservable inputs.

(13)	Debt investment is on non-accrual status as of March 31, 2023.

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments

December 31, 2022

(Dollars in thousands)

Portfolio Company (1)(3)	*Sector*	*Type of Investment (7)*	*Cash Rate (4)*			*Index*	*Margin*			*Floor*			*Ceiling*			*ETP (10)*			*Maturity Date*	*Principal Amount*		*Cost of Investments (6)(9)*		*Fair Value (9)*
Non-Affiliate Investments — 226.1% (8)
Non-Affiliate Debt Investments — 215.5% (8)
Non-Affiliate Debt Investments — Life Science — 99.7% (8)
Avalo Therapeutics, Inc. (2)(5)(12)	Biotechnology	Term Loan		13.75	%	Prime		6.25	%		9.50	%		-			3.00	%	January 1, 2025	$	2,885	$	2,853	$	2,777
		Term Loan		13.75	%	Prime		6.25	%		9.50	%		-			3.00	%	January 1, 2025		2,885		2,823		2,750
		Term Loan		13.75	%	Prime		6.25	%		9.50	%		-			3.00	%	January 1, 2025		1,442		1,411		1,374
		Term Loan		13.75	%	Prime		6.25	%		9.50	%		-			3.00	%	February 1, 2025		2,885		2,821		2,748
		Term Loan		13.75	%	Prime		6.25	%		9.50	%		-			3.00	%	February 1, 2025		2,885		2,821		2,748
		Term Loan		13.75	%	Prime		6.25	%		9.50	%		-			3.00	%	April 1, 2025		1,442		1,408		1,371
		Term Loan		13.75	%	Prime		6.25	%		9.50	%		-			3.00	%	April 1, 2025		1,442		1,408		1,371
Castle Creek Biosciences, Inc. (2)(12)	Biotechnology	Term Loan		12.50	%	Prime		6.05	%		9.55	%		13.50	%		5.50	%	May 1, 2026		5,000		4,891		4,891
		Term Loan		12.50	%	Prime		6.05	%		9.55	%		13.50	%		5.50	%	May 1, 2026		5,000		4,963		4,963
		Term Loan		12.50	%	Prime		6.05	%		9.55	%		13.50	%		5.50	%	May 1, 2026		3,000		2,978		2,978
		Term Loan		12.50	%	Prime		6.05	%		9.55	%		13.50	%		5.50	%	May 1, 2026		5,000		4,963		4,963
		Term Loan		12.50	%	Prime		6.05	%		9.55	%		13.50	%		5.50	%	May 1, 2026		5,000		4,963		4,963
		Term Loan		12.50	%	Prime		6.05	%		9.55	%		13.50	%		5.50	%	May 1, 2026		3,000		2,978		2,978
Emalex Biosciences, Inc. (2)(12)	Biotechnology	Term Loan		12.07	%	Libor		7.90	%		9.75	%		-			5.00	%	June 1, 2024		1,979		1,962		1,962
		Term Loan		12.07	%	Libor		7.90	%		9.75	%		-			5.00	%	June 1, 2024		1,979		1,963		1,963
		Term Loan		12.07	%	Libor		7.90	%		9.75	%		-			5.00	%	November 1, 2025		5,000		4,923		4,923
		Term Loan		12.07	%	Libor		7.90	%		9.75	%		-			5.00	%	May 1, 2026		5,000		4,912		4,912
Evelo Biosciences, Inc. (2)(5)(12)	Biotechnology	Term Loan		11.75	%	Prime		4.75	%		11.00	%		-			4.25	%	January 1, 2028		10,000		9,872		9,872
		Term Loan		11.75	%	Prime		4.75	%		11.00	%		-			4.25	%	January 1, 2028		15,000		14,808		14,808
		Term Loan		11.75	%	Prime		4.75	%		11.00	%		-			4.25	%	January 1, 2028		6,000		5,923		5,923
		Term Loan		11.75	%	Prime		4.75	%		11.00	%		-			4.25	%	January 1, 2028		6,000		5,923		5,923
		Term Loan		11.75	%	Prime		4.75	%		11.00	%		-			4.25	%	January 1, 2028		4,000		3,949		3,949
		Term Loan		11.75	%	Prime		4.75	%		11.00	%		-			4.25	%	January 1, 2028		4,000		3,949		3,949
F-Star Therapeutics, Inc. (2)(5)(12)	Biotechnology	Term Loan		13.25	%	Prime		6.25	%		9.50	%		-			4.00	%	April 1, 2025		2,500		2,476		2,476
		Term Loan		13.25	%	Prime		6.25	%		9.50	%		-			4.00	%	July 1, 2025		2,500		2,473		2,473
Greenlight Biosciences, Inc. (2)(5)(12)	Biotechnology	Term Loan		13.25	%	Prime		5.75	%		9.00	%		-			3.00	%	July 1, 2025		5,000		4,857		4,857
		Term Loan		13.25	%	Prime		5.75	%		9.00	%		-			3.00	%	July 1, 2025		2,500		2,430		2,430
IMV Inc. (2)(5)(12)	Biotechnology	Term Loan		13.25	%	Prime		5.75	%		9.00	%		-			5.00	%	July 1, 2025		5,000		4,946		4,946
		Term Loan		13.25	%	Prime		5.75	%		9.00	%		-			5.00	%	July 1, 2025		2,500		2,473		2,473
		Term Loan		13.25	%	Prime		5.75	%		9.00	%		-			5.00	%	January 1, 2026		5,000		4,947		4,947
		Term Loan		13.25	%	Prime		5.75	%		9.00	%		-			5.00	%	January 1, 2026		5,000		4,947		4,947
KSQ Therapeutics, Inc. (2) (12)	Biotechnology	Term Loan		12.25	%	Prime		4.75	%		8.50	%		-			5.50	%	May 1, 2027		6,250		6,077		6,077
		Term Loan		12.25	%	Prime		4.75	%		8.50	%		-			5.50	%	May 1, 2027		6,250		6,177		6,177
Native Microbials, Inc (2) (12)	Biotechnology	Term Loan		12.75	%	Prime		5.25	%		8.50	%		-			5.00	%	November 1, 2026		3,750		3,630		3,630
		Term Loan		12.75	%	Prime		5.25	%		8.50	%		-			5.00	%	November 1, 2026		2,500		2,469		2,469
PDS Biotechnology Corporation (2)(5)(12)	Biotechnology	Term Loan		13.25	%	Prime		5.75	%		9.75	%		-			3.75	%	September 1, 2026		10,000		9,701		9,701
		Term Loan		13.25	%	Prime		5.75	%		9.75	%		-			3.75	%	September 1, 2026		3,750		3,697		3,697
		Term Loan		13.25	%	Prime		5.75	%		9.75	%		-			3.75	%	September 1, 2026		3,750		3,697		3,697
Provivi, Inc. (2)(12)	Biotechnology	Term Loan		12.67	%	Libor		8.50	%		9.50	%		-			5.50	%	December 1, 2024		4,667		4,597		4,597
		Term Loan		12.67	%	Libor		8.50	%		9.50	%		-			5.50	%	December 1, 2024		4,667		4,597		4,597
		Term Loan		12.67	%	Libor		8.50	%		9.50	%		-			5.50	%	December 1, 2024		2,333		2,280		2,280
		Term Loan		12.67	%	Libor		8.50	%		9.50	%		-			5.50	%	December 1, 2024		2,333		2,280		2,280
		Term Loan		12.67	%	Libor		8.50	%		9.50	%		-			5.50	%	December 1, 2024		2,333		2,274		2,274
		Term Loan		12.67	%	Libor		8.50	%		9.50	%		-			5.50	%	December 1, 2024		2,333		2,274		2,274
Stealth Biotherapeutics Inc. (2)(12)	Biotechnology	Term Loan		13.00	%	Prime		5.50	%		8.75	%		-			6.00	%	October 1, 2025		5,000		4,914		4,914
		Term Loan		13.00	%	Prime		5.50	%		8.75	%		-			6.00	%	October 1, 2025		2,500		2,457		2,457
Aerobiotix, LLC (2)(12)	Medical Device	Term Loan		13.75	%	Prime		6.25	%		9.50	%		-			6.00	%	April 1, 2026		2,500		2,463		2,364
		Term Loan		13.75	%	Prime		6.25	%		9.50	%		-			6.00	%	April 1, 2026		2,500		2,463		2,364
Canary Medical Inc. (2)(12)	Medical Device	Term Loan		12.75	%	Prime		5.75	%		9.00	%		-			7.00	%	November 1, 2024		2,500		2,475		2,475
		Term Loan		12.75	%	Prime		5.75	%		9.00	%		-			7.00	%	November 1, 2024		2,500		2,489		2,489
		Term Loan		12.75	%	Prime		5.75	%		9.00	%		-			7.00	%	November 1, 2024		2,500		2,473		2,473
Ceribell, Inc. (2)(12)	Medical Device	Term Loan		10.50	%	Prime		3.50	%		8.25	%		-			5.50	%	October 1, 2024		5,000		4,973		4,973
		Term Loan		10.50	%	Prime		3.50	%		8.25	%		-			5.50	%	October 1, 2024		5,000		4,973		4,973
		Term Loan		10.50	%	Prime		3.50	%		8.25	%		-			5.50	%	October 1, 2024		2,500		2,478		2,478
		Term Loan		10.50	%	Prime		3.50	%		8.25	%		-			5.50	%	October 1, 2024		2,500		2,478		2,478
Cognoa, Inc. (2)(12)	Medical Device	Term Loan		13.00	%	Prime		5.50	%		8.75	%		-			6.00	%	August 1, 2026		2,500		2,466		2,466
		Term Loan		13.00	%	Prime		5.50	%		8.75	%		-			6.00	%	August 1, 2026		5,000		4,932		4,932
Conventus Orthopaedics, Inc. (2)(12)	Medical Device	Term Loan		12.17	%	Libor		8.00	%		9.25	%		-			10.36	%	July 1, 2025		3,960		3,898		3,898
		Term Loan		12.17	%	Libor		8.00	%		9.25	%		-			10.36	%	July 1, 2025		3,960		3,898		3,898

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments

December 31, 2022

(Dollars in thousands)

Portfolio Company (1)(3)	*Sector*	*Type of Investment (7)*	*Cash Rate (4)*			*Index*	*Margin*			*Floor*			*Ceiling*		*ETP (10)*			*Maturity Date*	*Principal Amount*		*Cost of Investments (6)(9)*		*Fair Value (9)*
Corinth Medtech, Inc. (2)(12)	Medical Device	Term Loan		12.25	%	Prime		5.25	%		8.50	%		-		20.00	%	September 15, 2022		2,500		2,500		2,500
		Term Loan		12.25	%	Prime		5.25	%		8.50	%		-		20.00	%	September 15, 2022		2,500		2,500		2,500
CSA Medical, Inc. (2)(12)	Medical Device	Term Loan		12.37	%	Libor		8.20	%		10.00	%		-		5.00	%	January 1, 2024		1,625		1,610		1,610
		Term Loan		12.37	%	Libor		8.20	%		10.00	%		-		5.00	%	January 1, 2024		108		107		107
		Term Loan		12.37	%	Libor		8.20	%		10.00	%		-		5.00	%	March 1, 2024		2,000		1,983		1,983
Embody, Inc. (2)(12)	Medical Device	Term Loan		14.00	%	Prime		6.50	%		9.75	%		-		28.00	%	August 1, 2026		2,500		2,482		2,482
InfoBionic, Inc. (2)(12)	Medical Device	Term Loan		13.25	%	Prime		6.25	%		9.50	%		-		4.00	%	October 1, 2024		3,208		3,143		3,143
		Term Loan		13.25	%	Prime		6.25	%		9.50	%		-		4.00	%	June 1, 2025		1,000		974		974
Magnolia Medical Technologies, Inc. (2)(12)	Medical Device	Term Loan		12.00	%	Prime		5.00	%		9.75	%		-		4.00	%	March 1, 2025		5,000		4,939		4,939
		Term Loan		12.00	%	Prime		5.00	%		9.75	%		-		4.00	%	March 1, 2025		5,000		4,939		4,939
		Term Loan		12.00	%	Prime		5.00	%		9.75	%		-		4.00	%	March 1, 2025		5,000		4,933		4,933
		Term Loan		12.00	%	Prime		5.00	%		9.75	%		-		4.00	%	March 1, 2025		5,000		4,933		4,933
		Term Loan		12.50	%	Prime		5.00	%		9.75	%		-		4.00	%	January 1, 2027		5,000		4,913		4,913
		Term Loan		12.50	%	Prime		5.00	%		9.75	%		-		4.00	%	January 1, 2027		5,000		4,913		4,913
Robin Healthcare, Inc. (2)(12)	Medical Device	Term Loan		13.00	%	Prime		5.50	%		10.25	%		-		4.00	%	November 1, 2026		3,500		3,360		3,360
		Term Loan		13.00	%	Prime		5.50	%		10.25	%		-		4.00	%	November 1, 2026		3,500		3,460		3,460
Scientia Vascular, Inc. (2)(12)	Medical Device	Term Loan		11.75	%	Prime		4.75	%		8.50	%		-		5.00	%	January 1, 2027		3,750		3,597		3,597
		Term Loan		11.75	%	Prime		4.75	%		8.50	%		-		5.00	%	January 1, 2027		3,750		3,706		3,706
Sonex Health, Inc. (2)(12)	Medical Device	Term Loan		13.50	%	Prime		6.50	%		9.75	%		-		8.00	%	June 1, 2025		2,500		2,476		2,476
		Term Loan		13.50	%	Prime		6.50	%		9.75	%		-		8.00	%	June 1, 2025		2,500		2,476		2,476
		Term Loan		13.50	%	Prime		6.50	%		9.75	%		-		8.00	%	June 1, 2025		2,500		2,476		2,476
		Term Loan		13.50	%	Prime		6.50	%		9.75	%		-		8.00	%	April 1, 2026		2,500		2,453		2,453
		Term Loan		13.50	%	Prime		6.50	%		9.75	%		-		8.00	%	May 1, 2026		2,500		2,455		2,455
Spineology, Inc. (2)(12)	Medical Device	Term Loan		14.50	%	Prime		7.00	%		10.25	%		-		1.00	%	October 1, 2025		5,000		4,966		4,966
		Term Loan		14.50	%	Prime		7.00	%		10.25	%		-		1.00	%	April 1, 2026		2,500		2,481		2,481
Swift Health Systems Inc. (2)(12)	Medical Device	Term Loan		12.25	%	Prime		5.25	%		9.00	%		-		5.00	%	July 1, 2027		3,500		3,349		3,349
		Term Loan		12.25	%	Prime		5.25	%		9.00	%		-		5.00	%	July 1, 2027		3,500		3,454		3,454
Total Non-Affiliate Debt Investments — Life Science																						318,172		317,568
Non-Affiliate Debt Investments — Sustainability — 26.3% (8)
Aerofarms, Inc. (2)(12)	Other Sustainability	Term Loan		14.25	%	Prime		6.75	%		10.00	%		-		3.00	%	April 1, 2026		3,750		3,699		3,699
		Term Loan		14.25	%	Prime		6.75	%		10.00	%		-		3.00	%	April 1, 2026		3,750		3,699		3,699
Nexii Building Solutions, Inc. (2)(12)	Other Sustainability	Term Loan		14.50	%	Prime		7.00	%		10.25	%		-		2.50	%	September 1, 2025		7,500		7,371		7,371
		Term Loan		14.50	%	Prime		7.00	%		10.25	%		-		2.50	%	September 1, 2025		7,500		7,371		7,371
		Term Loan		14.50	%	Prime		7.00	%		10.25	%		-		2.50	%	September 1, 2025		7,500		7,371		7,371
		Term Loan		14.50	%	Prime		7.00	%		10.25	%		-		2.50	%	July 1, 2026		5,000		4,903		4,903
		Term Loan		14.50	%	Prime		7.00	%		10.25	%		-		2.50	%	July 1, 2026		5,000		4,903		4,903
Soli Organic, Inc. (2)(12)	Other Sustainability	Term Loan		14.25	%	Prime		6.75	%		10.00	%		-		2.75	%	April 1, 2026		2,500		2,463		2,463
		Term Loan		14.25	%	Prime		6.75	%		10.00	%		-		2.75	%	April 1, 2026		5,000		4,927		4,927
		Term Loan		14.25	%	Prime		6.75	%		10.00	%		-		2.75	%	May 1, 2026		5,000		4,924		4,924
		Term Loan		14.25	%	Prime		6.75	%		10.00	%		-		2.75	%	May 1, 2026		2,500		2,462		2,462
		Term Loan		13.00	%	Prime		5.50	%		10.00	%		-		2.75	%	December 1, 2026		5,000		4,900		4,900
		Term Loan		13.00	%	Prime		5.50	%		10.00	%		-		2.75	%	December 1, 2026		2,500		2,450		2,450
Temperpack Technologies, Inc. (2)(12)	Other Sustainability	Term Loan		14.25	%	Prime		6.75	%		10.00	%		-		2.50	%	June 1, 2025		3,750		3,697		3,697
		Term Loan		14.25	%	Prime		6.75	%		10.00	%		-		2.50	%	June 1, 2025		3,750		3,717		3,717
		Term Loan		14.25	%	Prime		6.75	%		10.00	%		-		2.50	%	October 1, 2025		7,500		7,424		7,424
		Term Loan		14.25	%	Prime		6.75	%		10.00	%		-		2.50	%	October 1, 2025		3,750		3,712		3,712
		Term Loan		14.25	%	Prime		6.75	%		10.00	%		-		2.50	%	October 1, 2025		3,750		3,712		3,712
Total Non-Affiliate Debt Investments — Sustainability																						83,705		83,705
Non-Affiliate Debt Investments — Technology — 81.4% (8)
Axiom Space, Inc. (2)(12)	Communications	Term Loan		13.00	%	Prime		6.00	%		9.25	%		-		2.50	%	June 1, 2026		7,500		7,455		7,455
		Term Loan		13.00	%	Prime		6.00	%		9.25	%		-		2.50	%	June 1, 2026		7,500		7,455		7,455
		Term Loan		13.00	%	Prime		6.00	%		9.25	%		-		2.50	%	June 1, 2026		7,500		7,455		7,455
		Convertible Note		3.00	%													July 1, 2023		250		250		306
Alula Holdings, Inc. (2)(12)	Consumer-related Technologies	Term Loan		13.75	%	Prime		6.75	%		10.00	%		-		3.00	%	January 1, 2025		5,000		4,966		4,966
		Term Loan		13.75	%	Prime		6.75	%		10.00	%		-		3.00	%	January 1, 2025		5,000		4,966		4,966
		Term Loan		13.75	%	Prime		6.75	%		10.00	%		-		3.00	%	January 1, 2025		3,000		2,979		2,979
		Term Loan		13.75	%	Prime		6.75	%		10.00	%		-		3.00	%	December 1, 2025		1,000		976		976
		Term Loan		13.75	%	Prime		6.75	%		10.00	%		-		3.00	%	February 1, 2026		1,000		977		977
Better Place Forests Co. (2)(12)(13)	Consumer-related Technologies	Term Loan		13.75	%	Prime		6.25	%		9.50	%		-		1.85	%	July 1, 2025		5,000		4,951		3,834
		Term Loan		13.75	%	Prime		6.25	%		9.50	%		-		1.85	%	October 1, 2025		2,500		2,474		1,916
CAMP NYC, Inc. (2)(12)	Consumer-related Technologies	Term Loan		14.75	%	Prime		7.25	%		10.50	%		-		3.00	%	May 1, 2026		3,500		3,461		3,461
Clara Foods Co. (2)(12)	Consumer-related Technologies	Term Loan		12.75	%	Prime		5.75	%		9.00	%		-		5.50	%	August 1, 2025		2,500		2,482		2,482
		Term Loan		12.75	%	Prime		5.75	%		9.00	%		-		5.50	%	August 1, 2025		2,500		2,482		2,482

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments

December 31, 2022

(Dollars in thousands)

Portfolio Company (1)(3)	*Sector*	*Type of Investment (7)*	*Cash Rate (4)*			*Index*	*Margin*			*Floor*			*Ceiling*			*ETP (10)*			*Maturity Date*	*Principal Amount*		*Cost of Investments (6)(9)*		*Fair Value (9)*
Divergent Technologies, Inc. (2)(12)	Consumer-related Technologies	Term Loan		11.25	%	Prime		6.00	%		9.50	%		11.25	%		3.00	%	July 1, 2027		3,750		3,478		3,478
		Term Loan		11.25	%	Prime		6.00	%		9.50	%		11.25	%		3.00	%	July 1, 2027		1,250		1,238		1,238
		Term Loan		11.25	%	Prime		6.00	%		9.50	%		11.25	%		3.00	%	July 1, 2027		3,750		3,715		3,715
		Term Loan		11.25	%	Prime		6.00	%		9.50	%		11.25	%		3.00	%	July 1, 2027		1,250		1,238		1,238
		Term Loan		11.25	%	Prime		6.00	%		9.50	%		11.25	%		3.00	%	July 1, 2027		3,750		3,715		3,715
		Term Loan		11.25	%	Prime		6.00	%		9.50	%		11.25	%		3.00	%	July 1, 2027		1,250		1,238		1,238
		Term Loan		11.25	%	Prime		6.00	%		9.50	%		11.25	%		3.00	%	January 1, 2028		3,750		3,698		3,698
		Term Loan		11.25	%	Prime		6.00	%		9.50	%		11.25	%		3.00	%	January 1, 2028		3,750		3,698		3,698
Havenly, Inc. (2)(12)	Consumer-related Technologies	Term Loan		12.50	%	Prime		5.00	%		5.00	%		-			4.00	%	March 1, 2027		2,000		1,082		1,082
		Term Loan		12.50	%	Prime		5.00	%		5.00	%		-			4.00	%	March 1, 2027		3,000		1,623		1,623
		Term Loan		11.00	%	Prime		3.50	%		10.50	%		-			7.78	%	February 1, 2028		2,813		2,813		2,813
		Term Loan		11.00	%	Prime		3.50	%		10.50	%		-			7.78	%	February 1, 2028		2,813		2,813		2,813
Interior Define, Inc. (2)(12)(13)	Consumer-related Technologies	Term Loan		13.50	%	Prime		6.50	%		9.75	%		-			4.00	%	January 1, 2026		3,210		3,151		—
		Term Loan		13.50	%	Prime		6.50	%		9.75	%		-			4.00	%	January 1, 2026		2,963		2,886		—
Lyrical Foods, Inc. (2)(12)	Consumer-related Technologies	Term Loan		10.00	%	Prime		6.75	%		10.00	%		-			-		September 1, 2027		2,500		2,588		2,279
MyForest Foods Co. (2)(12)	Consumer-related Technologies	Term Loan		14.25	%	Prime		6.75	%		10.00	%		-			3.00	%	October 1, 2025		5,000		4,954		4,954
		Term Loan		14.25	%	Prime		6.75	%		10.00	%		-			3.00	%	October 1, 2025		2,500		2,477		2,477
NextCar Holding Company, Inc. (2)(12)	Consumer-related Technologies	Term Loan		12.75	%	Prime		5.75	%		9.00	%		-			2.00	%	December 30, 2022		5,000		4,943		4,715
		Term Loan		12.75	%	Prime		5.75	%		9.00	%		-			2.00	%	December 30, 2022		2,000		1,981		1,890
		Term Loan		12.75	%	Prime		5.75	%		9.00	%		-			2.00	%	December 30, 2022		2,500		2,477		2,363
		Term Loan		12.75	%	Prime		5.75	%		9.00	%		-			2.00	%	December 30, 2022		3,000		2,971		2,835
		Term Loan		12.75	%	Prime		5.75	%		9.00	%		-			2.00	%	December 30, 2022		2,500		2,459		2,345
		Term Loan		12.75	%	Prime		5.75	%		9.00	%		-			2.00	%	December 30, 2022		2,500		2,459		2,345
		Term Loan		12.75	%	Prime		5.75	%		9.00	%		-			2.00	%	December 30, 2022		5,000		4,914		4,688
		Term Loan		12.75	%	Prime		5.75	%		9.00	%		-			2.00	%	December 30, 2022		2,500		2,456		2,342
Optoro, Inc. (2)(12)	Consumer-related Technologies	Term Loan		13.25	%	Prime		6.25	%		9.50	%		-			4.00	%	August 1, 2027		2,500		2,347		2,347
Primary Kids, Inc. (2)(12)	Consumer-related Technologies	Term Loan		14.25	%	Prime		7.25	%		10.50	%		-			3.00	%	March 1, 2025		2,700		2,673		2,673
		Term Loan		14.25	%	Prime		7.25	%		10.50	%		-			3.00	%	March 1, 2025		2,700		2,673		2,673
		Term Loan		14.25	%	Prime		7.25	%		10.50	%		-			3.00	%	September 1, 2025		3,000		2,967		2,967
Unagi, Inc. (2)(12)	Consumer-related Technologies	Term Loan		15.25	%	Prime		7.75	%		11.00	%		-			-		July 1, 2025		2,500		2,473		2,473
		Term Loan		15.25	%	Prime		7.75	%		11.00	%		-			-		July 1, 2025		1,250		1,236		1,236
		Term Loan		15.25	%	Prime		7.75	%		11.00	%		-			-		July 1, 2025		1,250		1,236		1,236
Liqid, Inc. (2)(12)	Networking	Term Loan		13.25	%	Prime		6.25	%		9.50	%		-			4.00	%	September 1, 2024		3,333		3,286		3,286
		Term Loan		13.25	%	Prime		6.25	%		9.50	%		-			4.00	%	September 1, 2024		3,333		3,286		3,286
		Term Loan		13.25	%	Prime		6.25	%		9.50	%		-			4.00	%	September 1, 2024		1,667		1,641		1,641
		Term Loan		13.25	%	Prime		6.25	%		9.50	%		-			4.00	%	September 1, 2024		1,667		1,641		1,641
		Term Loan		13.25	%	Prime		6.25	%		9.50	%		-			4.00	%	September 1, 2024		1,667		1,613		1,613
BriteCore Holdings, Inc. (2)(12)	Software	Term Loan		13.75	%	Prime		6.75	%		10.00	%		-			5.00	%	March 1, 2026		2,500		2,421		2,421
		Term Loan		13.75	%	Prime		6.75	%		10.00	%		-			5.00	%	March 1, 2026		2,500		2,487		2,487
Decisyon, Inc. (12)	Software	Term Loan		16.93	%	Prime		9.43	%		12.68	%		-			50.43	%	December 31, 2022		3,295		3,295		3,295
Dropoff, Inc. (2)(12)	Software	Term Loan		14.00	%	Prime		6.50	%		9.75	%		-			3.50	%	April 1, 2026		6,500		6,347		6,347
		Term Loan		14.00	%	Prime		6.50	%		9.75	%		-			3.50	%	April 1, 2026		6,000		5,859		5,859
		Term Loan		14.00	%	Prime		6.50	%		9.75	%		-			3.50	%	August 1, 2026		2,500		2,436		2,436
Engage3, LLC (2)(12)	Software	Term Loan		13.25	%	Prime		6.25	%		9.75	%		-			4.50	%	July 1, 2027		3,750		3,678		3,678
		Term Loan		13.25	%	Prime		6.25	%		9.75	%		-			4.50	%	July 1, 2027		3,750		3,718		3,718
Groundspeed Analytics, Inc. (2)(12)	Software	Term Loan		13.00	%	Prime		5.50	%		11.00	%		18.00	%		3.00	%	December 1, 2026		5,000		4,798		4,798
		Term Loan		13.00	%	Prime		5.50	%		11.00	%		18.00	%		3.00	%	December 1, 2026		5,000		4,948		4,948
Kodiak Robotics, Inc. (2)(12)	Software	Term Loan		13.00	%	Prime		5.50	%		10.25	%		-			4.00	%	April 1, 2026		10,000		9,826		9,826
		Term Loan		13.00	%	Prime		5.50	%		10.25	%		-			4.00	%	April 1, 2026		10,000		9,826		9,826
		Term Loan		13.00	%	Prime		5.50	%		10.25	%		-			4.00	%	April 1, 2026		5,000		4,913		4,913
		Term Loan		13.00	%	Prime		5.50	%		10.25	%		-			4.00	%	April 1, 2026		5,000		4,913		4,913
Lemongrass Holdings, Inc. (2)(12)	Software	Term Loan		14.00	%	Prime		6.50	%		9.75	%		-			2.50	%	March 1, 2026		5,000		4,947		4,947
		Term Loan		14.00	%	Prime		6.50	%		9.75	%		-			2.50	%	March 1, 2026		2,500		2,474		2,474
Lytics, Inc. (2)(12)	Software	Term Loan		13.00	%	Prime		6.00	%		9.25	%		-			3.00	%	July 1, 2025		2,500		2,396		2,396
		Term Loan		13.00	%	Prime		6.00	%		12.25	%		-			3.00	%	December 1, 2026		1,250		1,231		1,231
Reputation Institute, Inc. (2)(12)	Software	Term Loan		14.25	%	Prime		7.25	%		10.50	%		-			3.00	%	August 1, 2025		5,000		4,932		4,932
Slingshot Aerospace, Inc. (2)(12)	Software	Term Loan		13.25	%	Prime		5.75	%		9.75	%		-			5.00	%	August 1, 2026		5,000		4,870		4,870
		Term Loan		13.25	%	Prime		5.75	%		9.75	%		-			5.00	%	August 1, 2026		5,000		4,933		4,933
		Term Loan		13.25	%	Prime		5.75	%		9.75	%		-			5.00	%	August 1, 2026		5,000		4,933		4,933
		Term Loan		13.25	%	Prime		5.75	%		9.75	%		-			5.00	%	August 1, 2026		5,000		4,933		4,933
Supply Network Visiblity Holdings LLC (2)(12)	Software	Term Loan		13.50	%	Prime		6.50	%		9.75	%		-			4.00	%	February 1, 2025		3,500		3,472		3,472
		Term Loan		13.50	%	Prime		6.50	%		9.75	%		-			4.00	%	February 1, 2025		3,500		3,472		3,472
		Term Loan		13.50	%	Prime		6.50	%		9.75	%		-			4.00	%	December 1, 2025		2,500		2,472		2,472
		Term Loan		13.50	%	Prime		6.50	%		9.75	%		-			4.00	%	December 1, 2025		2,500		2,472		2,472
Total Non-Affiliate Debt Investments — Technology																							268,468		259,366
Non-Affiliate Debt Investments — Healthcare information and services — 8.1% (8)
Hound Labs inc. (2) (12)	Diagnostics	Term Loan		13.50	%	Prime		6.00	%		9.25	%		-			3.50	%	June 1, 2026		2,500		2,385		2,385
		Term Loan		13.50	%	Prime		6.00	%		9.25	%		-			3.50	%	June 1, 2026		2,500		2,473		2,473
		Term Loan		13.50	%	Prime		6.00	%		9.25	%		-			3.50	%	June 1, 2026		5,000		4,946		4,946
Secure Transfusion Services, Inc. (2)(12)(13)	Other Healthcare	Term Loan		13.25	%	Prime		5.75	%		9.00	%		-			4.00	%	October 1, 2025		4,943		4,943		1,668
		Term Loan		13.25	%	Prime		5.75	%		9.00	%		-			4.00	%	December 31, 2025		2,500		2,467		832
BrightInsight, Inc. (2)(12)	Software	Term Loan		12.50	%	Prime		5.50	%		9.50	%		-			3.00	%	August 1, 2027		7,000		6,619		6,619
		Term Loan		12.50	%	Prime		5.50	%		9.50	%		-			3.00	%	August 1, 2027		3,500		3,448		3,448
		Term Loan		12.50	%	Prime		5.50	%		9.50	%		-			3.00	%	August 1, 2027		3,500		3,448		3,448
Total Non-Affiliate Debt Investments — Healthcare information and services																							30,729		25,819
*Total Non- Affiliate Debt Investments*																							701,074		686,458

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments

December 31, 2022

(Dollars in thousands)

					*Cost of*		*Fair*
Portfolio Company (1)(3)	*Sector*	*Type of Investment (7)*	*Number of Shares*		*Investments (6)(9)*		*Value (9)*
Non-Affiliate Warrant Investments — 9.4% (8)
Non-Affiliate Warrants — Life Science — 3.1% (8)
Avalo Therapeutics, Inc. (2)(5)(12)	Biotechnology	Common Stock Warrant		26,442		311		—
Castle Creek Biosciences, Inc. (2)(12)	Biotechnology	Preferred Stock Warrant		7,404		214		335
Corvium, Inc. (2)(12)	Biotechnology	Preferred Stock Warrant		661,956		53		—
Emalex Biosciences, Inc. (2)(12)	Biotechnology	Preferred Stock Warrant		110,402		176		263
Evelo Biosciences, Inc. (2)(5)(12)	Biotechnology	Common Stock Warrant		463,915		126		125
F-Star Therapeutics, Inc. (2)(5)(12)	Biotechnology	Common Stock Warrant		21,120		35		—
Greenlight Biosciences, Inc. (2)(5)(12)	Biotechnology	Common Stock Warrant		47,452		366		—
Imunon, Inc. (2)(5)(12)	Biotechnology	Common Stock Warrant		16,502		66		—
IMV Inc. (2)(5)(12)	Biotechnology	Common Stock Warrant		39,774		67		—
KSQ Therapeutics, Inc. (2) (12)	Biotechnology	Preferred Stock Warrant		48,077		51		60
Mustang Bio, Inc. (2)(5)(12)	Biotechnology	Common Stock Warrant		252,161		146		—
Native Microbials, Inc (2) (12)	Biotechnology	Preferred Stock Warrant		103,679		64		162
PDS Biotechnology Corporation (2)(5)(12)	Biotechnology	Common Stock Warrant		299,848		160		3,024
Provivi, Inc. (2)(12)	Biotechnology	Preferred Stock Warrant		203,017		399		648
Rocket Pharmaceuticals Corporation (5)(12)	Biotechnology	Common Stock Warrant		7,051		17		14
Stealth Biotherapeutics Inc. (2)(12)	Biotechnology	Common Stock Warrant		318,181		264		37
vTv Therapeutics Inc. (2)(5)(12)	Biotechnology	Common Stock Warrant		95,293		44		—
Xeris Pharmaceuticals, Inc. (2)(5)(12)	Biotechnology	Common Stock Warrant		126,000		72		3
AccuVein Inc. (2)(12)	Medical Device	Common Stock Warrant		1,175		24		—
Aerin Medical, Inc. (2)(12)	Medical Device	Preferred Stock Warrant		1,818,183		64		1,200
Aerobiotix, LLC (2)(12)	Medical Device	Preferred Stock Warrant		27,330		48		31
Canary Medical Inc. (2)(12)	Medical Device	Preferred Stock Warrant		12,153		84		1,864
Ceribell, Inc. (2)(12)	Medical Device	Preferred Stock Warrant		145,483		69		209
Cognoa, Inc. (2)(12)	Medical Device	Preferred Stock Warrant		775,000		148		179
Conventus Orthopaedics, Inc. (2)(12)	Medical Device	Preferred Stock Warrant		7,972,222		221		226
CSA Medical, Inc. (2)(12)	Medical Device	Preferred Stock Warrant		1,375,727		153		150
CVRx, Inc. (2)(5)(12)	Medical Device	Common Stock Warrant		47,410		76		394
Infobionic, Inc. (2)(12)	Medical Device	Preferred Stock Warrant		317,647		124		113
Magnolia Medical Technologies, Inc. (2)(12)	Medical Device	Preferred Stock Warrant		809,931		194		385
Meditrina, Inc. (2)(12)	Medical Device	Preferred Stock Warrant		233,993		83		101
Robin Healthcare, Inc. (2)(12)	Medical Device	Preferred Stock Warrant		86,066		16		16
Scientia Vascular, Inc (2)(12)	Medical Device	Preferred Stock Warrant		19,662		40		46
Sonex Health, Inc. (2)(12)	Medical Device	Preferred Stock Warrant		605,313		98		123
VERO Biotech LLC (2)(12)	Medical Device	Preferred Stock Warrant		408		53		1
Swift Health Systems Inc. (2)(12)	Medical Device	Preferred Stock Warrant		135,484		71		83
Total Non-Affiliate Warrants — Life Science						4,197		9,792
Non-Affiliate Warrants — Sustainability — 0.6% (8)
Aerofarms, Inc. (2)(12)	Other Sustainability	Preferred Stock Warrant		201,537		61		74
LiquiGlide, Inc. (2)(12)	Other Sustainability	Common Stock Warrant		61,539		39		55
Nexii Building Solutions, Inc. (2)(12)	Other Sustainability	Common Stock Warrant		204,832		488		1,061
Soli Organic, Inc. (2)(12)	Other Sustainability	Preferred Stock Warrant		681		214		361
Temperpack Technologies, Inc. (2)(12)	Other Sustainability	Preferred Stock Warrant		35,906		126		268
Total Non-Affiliate Warrants — Sustainability						928		1,819

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments

December 31, 2022

(Dollars in thousands)

					*Cost of*		*Fair*
Portfolio Company (1)(3)	*Sector*	*Type of Investment (7)*	*Number of Shares*		*Investments (6)(9)*		*Value (9)*
Non-Affiliate Warrants — Technology — 5.1% (8)
Axiom Space, Inc. (2)(12)	Communications	Common Stock Warrant		1,991		46		67
Intelepeer Holdings, Inc. (2)(12)	Communications	Preferred Stock Warrant		2,936,535		139		3,265
PebblePost, Inc. (2)(12)	Communications	Preferred Stock Warrant		598,850		92		173
Alula Holdings, Inc. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		20,000		93		64
Aterian, Inc. (2)(5)(12)	Consumer-related Technologies	Common Stock Warrant		76,923		195		—
Better Place Forests Co. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		10,690		26		—
Caastle, Inc. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		268,591		68		1,069
CAMP NYC, Inc. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		17,605		20		61
Clara Foods Co. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		46,745		30		125
Divergent Technologies, Inc. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		31,966		56		233
Havenly, Inc. (2)(12)	Consumer-related Technologies	Common Stock Warrant		1,312,500		2,947		2,947
Interior Define, Inc. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		553,710		103		—
MyForest Foods Co. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		143		29		37
NextCar Holding Company, Inc. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		1,261,253		197		17
Optoro, Inc. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		6,600		104		104
Primary Kids, Inc. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		553,778		57		429
Quip NYC Inc. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		6,191		325		534
Unagi, Inc. (2)(12)	Consumer-related Technologies	Preferred Stock Warrant		171,081		32		22
Updater, Inc.(2)(12)	Consumer-related Technologies	Common Stock Warrant		108,333		34		42
CPG Beyond, Inc. (2)(12)	Data Storage	Preferred Stock Warrant		500,000		242		909
Silk, Inc. (2)(12)	Data Storage	Preferred Stock Warrant		442,110		234		407
Global Worldwide LLC (2)(12)	Internet and Media	Preferred Stock Warrant		245,810		75		—
Rocket Lawyer Incorporated (2)(12)	Internet and Media	Preferred Stock Warrant		261,721		92		357
Skillshare, Inc. (2)(12)	Internet and Media	Preferred Stock Warrant		139,074		162		802
Liqid, Inc. (2)(12)	Networking	Preferred Stock Warrant		344,102		364		243
Halio, Inc. (2)(12)	Power Management	Preferred Stock Warrant		5,002,574		1,585		2,610
Avalanche Technology, Inc. (2)(12)	Semiconductors	Preferred and Common Stock Warrants		6,081		56		—
BriteCore Holdings, Inc. (2)(12)	Software	Preferred Stock Warrant		77,828		21		69
Decisyon, Inc. (12)	Software	Common Stock Warrant		82,967		46		—
Dropoff, Inc. (2)(12)	Software	Common Stock Warrant		516,732		455		197
E La Carte, Inc. (2)(5)(12)	Software	Common Stock Warrant		147,361		60		3
Groundspeed Analytics, Inc. (2)(12)	Software	Preferred Stock Warrant		86,300		6		6
Kodiak Robotics, Inc. (2)(12)	Software	Preferred Stock Warrant		639,918		273		296
Lemongrass Holdings, Inc. (2)(12)	Software	Preferred Stock Warrant		101,308		34		41
Lotame Solutions, Inc. (2)(12)	Software	Preferred Stock Warrant		288,115		22		312
Lytics, Inc. (2)(12)	Software	Preferred Stock Warrant		80,197		40		44
Reputation Institute, Inc. (2)(12)	Software	Preferred Stock Warrant		3,731		56		39
Revinate Holdings, Inc. (2)(12)	Software	Preferred Stock Warrant		682,034		46		99
Riv Data Corp. (2)(12)	Software	Preferred Stock Warrant		321,428		12		296
SIGNiX, Inc. (12)	Software	Preferred Stock Warrant		186,235		225		—
Skyword, Inc. (12)	Software	Preferred and Common Stock Warrants		301,055		48		1
Slingshot Aerospace, Inc. (2)(12)	Software	Preferred Stock Warrant		309,208		123		133
Supply Network Visiblity Holdings LLC (2)(12)	Software	Preferred Stock Warrant		682		64		83
Topia Mobility, Inc. (2)(12)	Software	Preferred Stock Warrant		3,049,607		138		—
xAd, Inc. (2)(12)	Software	Preferred Stock Warrant		4,343,348		177		12
Total Non-Affiliate Warrants — Technology						9,249		16,148
*Non-Affiliate Warrants — Healthcare information and services — 0.6% (8)*
Hound Labs, Inc (2) (12)	Diagnostics	Preferred Stock Warrant		159,893		47		54
Kate Farms, Inc. (2)(12)	Other Healthcare	Preferred Stock Warrant		82,965		102		1,370
Secure Transfusion Services, Inc. (2)(12)	Other Healthcare	Preferred Stock Warrant		77,690		47		—
BrightInsight, Inc. (2)(12)	Software	Preferred Stock Warrant		80,544		160		170
Medsphere Systems Corporation (2)(12)	Software	Preferred Stock Warrant		7,097,792		60		359
Total Non-Affiliate Warrants — Healthcare information and services						416		1,953
*Total Non-Affiliate Warrants*						14,790		29,712
Non-Affiliate Other Investments — 0.4% (8)
Lumithera, Inc. (2)	Medical Device	Royalty Agreement				1,200		1,100
ZetrOZ, Inc. (12)	Medical Device	Royalty Agreement				—		200
*Total Non-Affiliate Other Investments*						1,200		1,300
Non-Affiliate Equity — 0.8% (8)
Castle Creek Biosciences, Inc. (12)	Biotechnology	Common Stock		1,162		250		250
Emalex Biosciences, Inc. (2)(12)	Biotechnology	Common Stock		32,831		356		356
Getaround, Inc. (2)(5)	Consumer-related Technologies	Common Stock		87,082		253		57
SnagAJob.com, Inc. (12)	Consumer-related Technologies	Common Stock		82,974		8		83
Lumithera, Inc. (2)	Medical Device	Common Stock		392,651		2,000		1,700
Tigo Energy, Inc. (2)	Other Sustainability	Preferred		22,313		8		27
Branded Online, Inc. (2)(5)	Software	Common Stock		108,004		1,079		83
Decisyon, Inc. (12)	Software	Preferred and Common Stock		72,638,663		230		—
*Total Non-Affiliate Equity*						4,184		2,556
*Total Non-Affiliate Portfolio Investment Assets*					$	721,248	$	720,026
*Total Portfolio Investment Assets — 226.1% (8)*					$	721,248	$	720,026

(1)	All investments of the Company are in entities which are organized under the laws of the United States and have a principal place of business in the United States.

(2)	Has been pledged as collateral under the Key Facility, the NYL Facility the 2019 Asset-Backed Notes and/or the 2022 Asset-Backed Notes.

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments

December 31, 2022

(Dollars in thousands)

(3)

(4)

All interest is payable in cash due monthly in arrears, unless otherwise indicated, and applies only to the Company’s debt investments. Interest rate is the annual interest rate on the debt investment and does not include ETPs, and any additional fees related to the investments, such as deferred interest, commitment fees or prepayment fees. Debt investments are at variable rates for the term of the debt investment, unless otherwise indicated. All debt investments based on the LIBOR are based on one-month LIBOR. For each debt investment, the current interest rate in effect as of December 31, 2022 is provided.

(5)	Portfolio company is a public company.

(6)	For debt investments, represents principal balance less unearned income.

(7)	Warrants, Equity and Other Investments are non-income producing.

(8)	Value as a percent of net assets.

(9)

As of December 31, 2022, 6.5% and 6.6% of the Company's total assets on a cost and fair value basis, respectively, are in non-qualifying assets. Under the 1940 Act, the Company may not acquire any non-qualifying assets unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company’s total assets.

(10)

(11)	Debt investment has a PIK feature.

(12)	The fair value of the investment was valued using significant unobservable inputs.

(13)	Debt investment is on non-accrual status as of December 31, 2022.

See Notes to Consolidated Financial Statements